CatSci

CatSci Acquires Chromatography Provider Reach Separations

In a move to enhance its chemistry, manufacturing and controls (CMC) capabilities, UK-based process research and development contract research organization (CRO) CatSci has acquired chromatography provider Reach Separations. Financial details of the transaction were not disclosed.

Topics • Strategy

CatSci Appoints Paul Bradley as Head of Business Development

Top-Feature

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Aenova Holding GmbH

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

CatSci Ltd.